Skip to main content

TD Asset Management Inc

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in ALLO

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$961,126
-$630,934 QoQ
Shares Held
462,080
-29.2% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,140,636,067 across 120 Biotechnology names. ALLO ranks #103 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALLO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $961,126 462,080
2026-03-31 $1,592,060 652,484
2025-12-31 $567,281 414,074
2025-09-30 $513,451 414,074
2025-06-30 $616,288 545,388
2025-03-31 $796,266 545,388
2024-12-31 $1,161,676 545,388
2024-09-30 $1,895,992 677,140
2024-06-30 $1,862,462 799,340
2024-03-31 $1,955,338 437,436
2023-12-31 $763,453 237,836
2023-09-30 $753,940 237,836
2023-06-30 $991,410 199,479
2023-03-31 $857,974 173,679
2022-12-31 $1,092,440 173,679
2022-09-30 $1,778,533 164,679
2022-06-30 $1,458,892 127,973
2022-03-31 $1,114,818 122,373
2021-12-31 $1,628,861 109,173
2021-09-30 $2,862,080 111,365
2021-06-30 $2,390,910 91,676
2021-03-31 $2,877,126 81,505
2020-12-31 $1,965,514 77,873
2020-09-30 $2,929,350 77,681
2020-06-30 $3,531,836 82,481
2020-03-31 $1,055,106 54,275